Vaxcyte, Inc. Common Stock (PCVX) Financials
Key financial figures for Vaxcyte, Inc. Common Stock (Q2 2026).
- Revenue
- $0
- Net Income
- -$284M
- EPS
- $-1.97
- Total Assets
- $3.1B
- Operating Cash Flow
- -$232M
Full income statement, balance sheet, and cash flow for Vaxcyte, Inc. Common Stock on SentiSense.